Vertex Pharmaceuticals (VRTX) Goodwill & Intangibles (2009 - 2026)

Vertex Pharmaceuticals has reported Goodwill & Intangibles for 18 years, with the latest figure at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 1.48% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (down 1.48% YoY), and the FY2025 full-year result was $1.5 billion, down 20.99% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $1.5 billion, roughly flat from $1.5 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $1.9 billion in Q4 2023, with the low at $1.4 billion in Q2 2022.
• Average Goodwill & Intangibles over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
• Year-over-year, Goodwill & Intangibles increased 21.77% in 2023 and dropped 20.99% in 2025.
• Tracing VRTX's Goodwill & Intangibles over 5 years: stood at $1.7 billion in 2022, then climbed by 13.17% to $1.9 billion in 2023, then retreated by 0.73% to $1.9 billion in 2024, then retreated by 20.99% to $1.5 billion in 2025, then dropped by 0.38% to $1.5 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.

Peer Comparison